tiprankstipranks
Trending News
More News >
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market
Advertisement

TransMedics Group (TMDX) Stock Forecast & Price Target

Compare
1,489 Followers
See the Price Targets and Ratings of:

TMDX Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
Based on 9 analysts giving stock ratings to
TransMedics
Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TMDX Stock 12 Month Forecast

Average Price Target

$140.57
▲(34.09%Upside)
Based on 9 Wall Street analysts offering 12 month price targets for TransMedics Group in the last 3 months. The average price target is $140.57 with a high forecast of $170.00 and a low forecast of $114.00. The average price target represents a 34.09% change from the last price of $104.83.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"61":"$61","116":"$116","171":"$171","88.5":"$88.5","143.5":"$143.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$170.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":140.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$140.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$114.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[61,88.5,116,143.5,171],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.1,133.16923076923075,136.23846153846154,139.3076923076923,142.37692307692308,145.44615384615383,148.51538461538462,151.58461538461538,154.65384615384616,157.72307692307692,160.7923076923077,163.86153846153846,166.93076923076922,{"y":170,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.1,130.9053846153846,131.71076923076922,132.51615384615383,133.32153846153847,134.12692307692308,134.9323076923077,135.7376923076923,136.5430769230769,137.34846153846152,138.15384615384613,138.95923076923077,139.76461538461538,{"y":140.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.1,128.86153846153846,127.62307692307692,126.38461538461539,125.14615384615384,123.9076923076923,122.66923076923077,121.43076923076923,120.1923076923077,118.95384615384616,117.71538461538461,116.47692307692307,115.23846153846154,{"y":114,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":150.19,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.51,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.06,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.82,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.14,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.35,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.94,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$170.00Average Price Target$140.57Lowest Price Target$114.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TMDX
TipRanks AITipRanks
Not Ranked
TipRanks
$126
Hold
20.19%
Upside
Downgraded
07/16/25
The strong earnings call and positive financial performance are significant strengths, but technical indicators and valuation concerns, such as a high P/E ratio and negative cash flow, temper the overall score.
William Blair Analyst forecast on TMDX
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
07/28/25
Buy Rating for TransMedics Group Amid Strong Q2 Prospects and Seasonal Challenges
Needham
Hold
Reiterated
07/23/25
Cautious Optimism for TransMedics Group Amid Strong Growth Indicators
TD Cowen
$170
Buy
62.17%
Upside
Reiterated
07/21/25
TransMedics Group: Strong Market Position and Ethical Practices Justify Buy Rating Amid ControversiesWe do not see any direct implications to TransMedics' practices, but HHS could accelerate the restructuring of the US transplant network. We continue to believe that this ongoing overhaul could present share gain opportunities for TransMedics.
Robert W. Baird Analyst forecast on TMDX
Joseph VruwinkRobert W. Baird
Robert W. Baird
$140$148
Buy
41.18%
Upside
Reiterated
07/16/25
Robert W. Baird Keeps Their Buy Rating on TransMedics Group (TMDX)
Morgan Stanley Analyst forecast on TMDX
Patrick WoodMorgan Stanley
Morgan Stanley
$103$115
Hold
9.70%
Upside
Reiterated
07/15/25
Morgan Stanley Remains a Hold on TransMedics Group (TMDX)
Canaccord Genuity Analyst forecast on TMDX
William PlovanicCanaccord Genuity
Canaccord Genuity
$129$142
Buy
35.46%
Upside
Reiterated
07/14/25
TransMedics price target raised to $142 from $129 at CanaccordTransMedics price target raised to $142 from $129 at Canaccord
Piper Sandler Analyst forecast on TMDX
Matthew O'BrienPiper Sandler
Piper Sandler
$145
Buy
38.32%
Upside
Reiterated
07/02/25
Piper Sandler Sticks to Their Buy Rating for TransMedics Group (TMDX)
Oppenheimer Analyst forecast on TMDX
Suraj KaliaOppenheimer
Oppenheimer
$130$150
Buy
43.09%
Upside
Reiterated
06/17/25
TransMedics price target raised to $150 from $130 at OppenheimerTransMedics price target raised to $150 from $130 at Oppenheimer
J.P. Morgan Analyst forecast on TMDX
Allen GongJ.P. Morgan
J.P. Morgan
$81$114
Hold
8.75%
Upside
Reiterated
05/09/25
TransMedics Group (TMDX) PT Raised to $114 at JPMorganJPMorgan analyst Allen Gong raised the price target on TransMedics Group (NASDAQ: TMDX) to $114.00 (from $81.00) while maintaining a Neutral rating.
Nephron Analyst forecast on TMDX
Unknown AnalystNephron
Not Ranked
Nephron
$105
Buy
0.16%
Upside
Initiated
01/06/25
Nephron starts TransMedics Group (TMDX) at BuyNephron initiates coverage on TransMedics Group (NASDAQ: TMDX) with a Buy rating and a price target of $105.00.
Stephens
$151$178
Buy
69.80%
Upside
Reiterated
08/02/24
TransMedics Group (TMDX) PT Raised to $178 at StephensStephens analyst George Sellers raised the price target on TransMedics Group (NASDAQ: TMDX) to $178.00 (from $151.00) while maintaining a Overweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TMDX
TipRanks AITipRanks
Not Ranked
TipRanks
$126
Hold
20.19%
Upside
Downgraded
07/16/25
The strong earnings call and positive financial performance are significant strengths, but technical indicators and valuation concerns, such as a high P/E ratio and negative cash flow, temper the overall score.
William Blair Analyst forecast on TMDX
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
07/28/25
Buy Rating for TransMedics Group Amid Strong Q2 Prospects and Seasonal Challenges
Needham
Hold
Reiterated
07/23/25
Cautious Optimism for TransMedics Group Amid Strong Growth Indicators
TD Cowen
$170
Buy
62.17%
Upside
Reiterated
07/21/25
TransMedics Group: Strong Market Position and Ethical Practices Justify Buy Rating Amid ControversiesWe do not see any direct implications to TransMedics' practices, but HHS could accelerate the restructuring of the US transplant network. We continue to believe that this ongoing overhaul could present share gain opportunities for TransMedics.
Robert W. Baird Analyst forecast on TMDX
Joseph VruwinkRobert W. Baird
Robert W. Baird
$140$148
Buy
41.18%
Upside
Reiterated
07/16/25
Robert W. Baird Keeps Their Buy Rating on TransMedics Group (TMDX)
Morgan Stanley Analyst forecast on TMDX
Patrick WoodMorgan Stanley
Morgan Stanley
$103$115
Hold
9.70%
Upside
Reiterated
07/15/25
Morgan Stanley Remains a Hold on TransMedics Group (TMDX)
Canaccord Genuity Analyst forecast on TMDX
William PlovanicCanaccord Genuity
Canaccord Genuity
$129$142
Buy
35.46%
Upside
Reiterated
07/14/25
TransMedics price target raised to $142 from $129 at CanaccordTransMedics price target raised to $142 from $129 at Canaccord
Piper Sandler Analyst forecast on TMDX
Matthew O'BrienPiper Sandler
Piper Sandler
$145
Buy
38.32%
Upside
Reiterated
07/02/25
Piper Sandler Sticks to Their Buy Rating for TransMedics Group (TMDX)
Oppenheimer Analyst forecast on TMDX
Suraj KaliaOppenheimer
Oppenheimer
$130$150
Buy
43.09%
Upside
Reiterated
06/17/25
TransMedics price target raised to $150 from $130 at OppenheimerTransMedics price target raised to $150 from $130 at Oppenheimer
J.P. Morgan Analyst forecast on TMDX
Allen GongJ.P. Morgan
J.P. Morgan
$81$114
Hold
8.75%
Upside
Reiterated
05/09/25
TransMedics Group (TMDX) PT Raised to $114 at JPMorganJPMorgan analyst Allen Gong raised the price target on TransMedics Group (NASDAQ: TMDX) to $114.00 (from $81.00) while maintaining a Neutral rating.
Nephron Analyst forecast on TMDX
Unknown AnalystNephron
Not Ranked
Nephron
$105
Buy
0.16%
Upside
Initiated
01/06/25
Nephron starts TransMedics Group (TMDX) at BuyNephron initiates coverage on TransMedics Group (NASDAQ: TMDX) with a Buy rating and a price target of $105.00.
Stephens
$151$178
Buy
69.80%
Upside
Reiterated
08/02/24
TransMedics Group (TMDX) PT Raised to $178 at StephensStephens analyst George Sellers raised the price target on TransMedics Group (NASDAQ: TMDX) to $178.00 (from $151.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering TransMedics Group

1 Month
xxx
Success Rate
16/28 ratings generated profit
57%
Average Return
+5.99%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +5.99% per trade.
3 Months
xxx
Success Rate
17/28 ratings generated profit
61%
Average Return
+16.09%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +16.09% per trade.
1 Year
William PlovanicCanaccord Genuity
Success Rate
20/28 ratings generated profit
71%
Average Return
+48.65%
reiterated a buy rating 17 days ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +48.65% per trade.
2 Years
xxx
Success Rate
23/28 ratings generated profit
82%
Average Return
+98.70%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.14% of your transactions generating a profit, with an average return of +98.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMDX Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
6
4
1
0
2
Buy
7
10
14
19
20
Hold
5
6
6
8
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
20
21
27
33
In the current month, TMDX has received 22 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. TMDX average Analyst price target in the past 3 months is 140.57.
Each month's total comprises the sum of three months' worth of ratings.

TMDX Financial Forecast

TMDX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

TMDX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

TMDX Stock Forecast FAQ

What is TMDX’s average 12-month price target, according to analysts?
Based on analyst ratings, TransMedics Group Inc’s 12-month average price target is 140.57.
    What is TMDX’s upside potential, based on the analysts’ average price target?
    TransMedics Group Inc has 34.09% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TMDX a Buy, Sell or Hold?
          TransMedics Group Inc has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
            What is TransMedics Group Inc’s price target?
            The average price target for TransMedics Group Inc is 140.57. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $170.00 ,the lowest forecast is $114.00. The average price target represents 34.09% Increase from the current price of $104.83.
              What do analysts say about TransMedics Group Inc?
              TransMedics Group Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of TMDX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis